效果也是很不错的,具体严重程度每个人都不一样,晚期的话可能会比较严重,比如说有一些浑身疼痛的症状...
先后负责了10余项国家级科研课题和多项省部级科研课题 以第一或通讯作者在Blood、Cancer、Eur J Cancer等SCI杂志发表论著50余篇。参编7部肿瘤学专著 责任编辑:肿瘤资讯-小编 排版编辑:肿瘤资讯-XZY 版权声明
1.Osterman E, Hammarström K, Imam I, Osterlund E, Sjöblom T, Glimelius B. Recurrence risk after radical colorectal cancer surgery-less than before, but how high is it? Cancers (Basel). 2020;12(11):3308. 2...
[3]Shitara K, Rha S Y, Wyrwicz L S, et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study[J]. The Lancet Oncology, 2023....
[4]Yuan, Y., Egelston, C., Colunga Flores, O., et al. CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. Therapeutic advances in medical oncology, 15,17588359231210675. ...
第一篇我们来看看药物审批的终极大BOSS—FDA在Guidancefor Industry1 Clinical Trial Endpoints for the Approval of Cancer Drugs andBiologics中是如何定义这些研究终点的(以下是“Guidance”内容的精(cu)简(lue)筛(fan)选(yi)版)。 OS是指从病人随机化到任何原因引起的死亡的时间,并且需要在ITT(intent-to-treat...
由浙江大学医学院附属第一医院胡坚教授作为PI的阿美替尼辅助治疗研究数据,以电子壁报形式在2022年欧洲肺癌大会(ELCC)年会上公布。全文标题:Aumolertinib as Adjuvant Therapy in Postoperative EGFR-Mutated Non–Small-Cell Lung Cancer(阿美替尼作为EGFR突变阳性非小细胞肺癌术后辅助治疗)。
Huang, L., Pang, D., Yang, H. et al. Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial. Nat Commun 15, 2153 (2024). https://doi.org/10.1038/s41467-024-45591-7....
Cancer. N Engl J Med. 2018; 378(2): 113-125.3. Mok TS et al. Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. N Engl J Med. 2017; 376(7): 629-640.4. Herbsl et al. J Clin Oncol 2020.38 18_suppl LBA5.5. Tsuboi et al. ESMO 2020.Abstract LBA1.
Herbst RS, Wu YL, John T, et al. Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. J Clin Oncol. 2023 Jan 31:JCO2202186. doi: 10.1200/JCO.22.02186. Epub ahead of print. PMID: 36720083....